Skip to main content
. 2011 Apr 21;3(2):186–228. doi: 10.3390/pharmaceutics3020186

Table 11.

Zone I modifications based on mcf292-03.

graphic file with name pharmaceutics-03-00186t13.jpg

Entry Condition Structure Yield, % (from 21) Product

R2
1 tBuONO, TMSN3, MeCN, rt N3 38% mcf292-08
2 CSCl2, NaHCO3, CHCl3/H2O, rt NCS 41% mcf292-05
3 ClCH2COCl, 2,6-lutidine, DCM, rt NHCOCH2Cl 46% mcf292-09